Company
ReadyRx
ReadyRx publishes compounded semaglutide at $179 a month — First month, discounted (site shows a crossed-out reference price beside it).
- 1 program
- 1 molecule
- 1 reading
Read from readyrx.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to ReadyRx
We earn nothing from this link. ReadyRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · First month, discounted (site shows a crossed-out reference price beside it)
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. The product page is titled 'GLP-1 Injection Rx' and never names semaglutide vs. tirzepatide in the price block itself; it is tied to semaglutide only via a separate FAQ heading on the same page, 'What are the benefits of Semaglutide?'. There is no equivalent tirzepatide product page (nav only lists GLP-1 Injections, Glutathione, Metformin under 'Metabolic health'). The $179/$249 figure is rendered as adjacent strikethrough text in the DOM ('$179$249'), read here as a discounted first-month price against a $249 reference price; a banner also advertises 'LIMITED TIME DEAL: Extra $20 Off - Code: GETHEALTHY26', not applied here. Ongoing (non-promotional) monthly price is never stated. Controls show 'Monthly / Quarterly / One-time' tabs but clicking Quarterly did not change the visible price block.
Before you act
Cite this
Treatment Registry. (2026). ReadyRx: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/readyrx